RANDALL PETERSON
Professor
Pharmacology and Toxicology
RESEARCH INTERESTS
Developmental Biology
Small molecules are powerful tools for studying developmental biology because they provide timing and dosage control over developmental pathways that is difficult to achieve with genetic mutations. Unfortunately, only a handful of developmental pathways can currently be targeted with small molecules. We are discovering novel chemical modifiers of developmental pathways by exposing zebrafish embryos to libraries of structurally diverse small molecules and identifying those that induce specific developmental defects. Using screens of this type, we have discovered dozens of compounds that cause specific defects in hematopoesis, cardiac physiology, embryonic patterning, pigmentation, and morphogenesis of the heart, brain, ear, and eye and germ cell lineage.
Disease Physiology
One focus of our group is modeling human diseases in zebrafish. We then use the models to screen large chemical libraries for small molecule modulators of the disease-related phenotypes. The compounds we discover help us elucidate disease mechanisms and serve as starting points for developing new drug candidates.
Disease physiology is often complex and involves interactions between multiple organs and tissue types. Consequently, many diseases cannot be studied effectively using in vitro assays. The zebrafish is an excellent vertebrate model system to study many complex, non-cell autonomous diseases because the diseases can be studied in a native, whole-organism setting. In addition, compounds discovered in zebrafish screens have the advantage of having been selected for their ability to be active, efficacious, and well tolerated in animals.
Neuroscience & Behavior
Behaviors are accessible readouts of the molecular pathways that control neuronal signaling. Our group develops tools and techniques for comprehensive and high-throughput behavioral phenotyping in the zebrafish. These tools have some potential to improve our understanding of the neuronal signlaing and may accelerate the pace of neuroactive drug discovery.
Zebrafish Reverse Genetics
Zebrafish have proven to be a powerful genetic tool over the years, primarily through forward genetic screens where fish are mutagenized (typically with chemical agent) and screened for obvious defects. We are now on the verge of the next exciting step in zebrafish genetics: reverse genetics! Using targeted DNA disruption, we are now making designer mutations in specific genes of interest. Here are some of the resent papers describing three different processes.
GRANTS
- EXTERNAL GRANT OR CONTRACTTHE ROLE OF REDOX BALANCE IN CYANIDE TOXICITY AND MITOCHONDRIAL DISEASENIH NATL INST NEUROLOG DISORDERS STROKE1 Sep 2024 - 30 Aug 2025
- EXTERNAL GRANT OR CONTRACTMULTIMODAL PHENOTYPING OF ZEBRAFISH MODELS OF HUMAN DISEASE15 Jun 2024 - 31 May 2028
- EXTERNAL GRANT OR CONTRACTTHE ROLE OF REDOX BALANCE IN CYANIDE TOXICITY AND MITOCHONDRIAL DISEASENIH NATL INST NEUROLOG DISORDERS STROKE1 Sep 2023 - 31 Aug 2024
- EXTERNAL GRANT OR CONTRACTADVANCING GENE-EDITING NUCLEASES FOR DIVERSE ZEBRAFISH APPLICATIONS3 Jun 2023 - 31 Aug 2027
- EXTERNAL GRANT OR CONTRACTADVANCING GLYOXYLATE AS A CHEMICAL COUNTERMEASURE (PROJECT 2)BRIGHAM & WOMENS HOSPITAL1 Jun 2023 - 31 May 2025
- EXTERNAL GRANT OR CONTRACTADVANCING NOVEL CYANIDE COUNTERMEASURESBRIGHAM & WOMENS HOSPITAL1 Jun 2023 - 31 May 2025
- EXTERNAL GRANT OR CONTRACTIN VIVO FUNCTIONAL SCREEN OF NONCODING GENETIC ELEMENTS2 Sep 2022 - 31 Jan 2024
- EXTERNAL GRANT OR CONTRACTTHE ROLE OF REDOX BALANCE IN CYANIDE TOXICITY AND MITOCHONDRIAL DISEASE1 Sep 2022 - 31 Aug 2023
- EXTERNAL GRANT OR CONTRACTADVANCING GENE-EDITING NUCLEASES FOR DIVERSE ZEBRAFISH APPLICATIONS20 Sep 2019 - 31 Aug 2023
- EXTERNAL GRANT OR CONTRACTPENNY'S K99/R00NIH NATL INST NEUROLOG DISORDE9 Jan 2019 - 31 Dec 2020
- EXTERNAL GRANT OR CONTRACTBWH PROJECT 2BRIGHAM & WOMENS HOSPITAL8 Jan 2019 - 31 Dec 2022
- EXTERNAL GRANT OR CONTRACTTRAINING & EDUCATION COREBRIGHAM & WOMENS HOSPITAL8 Jan 2019 - 31 Dec 2022
- EXTERNAL GRANT OR CONTRACTPETERSON - GATESBILL & MELINDA GATES FOUNDATIO5 Jan 2017 - 31 Dec 2018
- EXTERNAL GRANT OR CONTRACTPETERSON - SUB - LONG QTMASSACHUSETTS GENERAL HOSPITAL4 Jan 2017 - 31 Dec 2020
- FELLOWSHIP OR RESIDENCYAHA FELLOWSHIP FOR PENNY LAMAMERICAN HEART ASSOCIATION1 Jan 2017 - 31 Dec 2018
- EXTERNAL GRANT OR CONTRACTCORE B U54 MGH114930BRIGHAM & WOMENS HOSPITAL1 Jan 2017 - 31 Dec 2018
- EXTERNAL GRANT OR CONTRACTNLGN3 AND TRANSLATIONHOFFMAN-LA ROCHE INC1 Jan 2017 - 11 Dec 2017
- EXTERNAL GRANT OR CONTRACTPETERSON SUB - BLOCHMASSACHUSETTS GENERAL HOSPITAL1 Jan 2017 - 31 Dec 2019
- EXTERNAL GRANT OR CONTRACTPROJECT 2 U54 MGH114928BRIGHAM & WOMENS HOSPITAL1 Jan 2017 - 31 Dec 2018
- EXTERNAL GRANT OR CONTRACTTEJIA ZHANGMASSACHUSETTS GENERAL HOSPITAL1 Jan 2017 - 31 Dec 2017
- EXTERNAL GRANT OR CONTRACTTRAINEESMASSACHUSETTS GENERAL HOSPITAL1 Jan 2017 - 31 Dec 2017
- EXTERNAL GRANT OR CONTRACTZEBRAFISH HEART FAILUREMERCK SHARP & DOHME LLC1 Jan 2017 - 31 Dec 2019